Clinical Trial Detail

NCT ID NCT02837042
Title Trial of Pembrolizumab for Advanced Penile Squamous Cell Carcinoma
Recruitment Terminated
Gender male
Phase Phase II
Variant Requirements No
Sponsors University of Alabama at Birmingham
Indications

sarcomatoid penile squamous cell carcinoma

Therapies

Pembrolizumab

Age Groups: senior adult

No variant requirements are available.